Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent bolus versus infusion ephedrine for hemodynamic prevention during cesarean section under spinal anesthesia
IRCT20250609066142N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ephedrine in maternal hypotension (3 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Systolic arterial blood pressure, Diastolic arterial blood pressure and 5 more. Started Sep 2025; status: completed.
02
Drugs
ephedrine
03
Conditions
maternal hypotension
Beyond the preview
Go deeper on IRCT20250609066142N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250609066142N1.